Neurodegenerative disease

Neurodegenerative disease research to receive £375m investment

The investment from the Government will improve the understanding and treatment for multiple neurodegenerative diseases.

A minimum of fifty million pounds will be invested specifically into research to help find a cure for motor neurone disease. Currently the disease affects over five thousand people in the UK and with the new investment experts hope they will be able to gain a better understanding of the condition and develop treatments to improve the care for those with MND.

The funding will go towards a range of neurodegenerative diseases such as Pick’s Disease, Fronto-temporal dementia, Wernicke-worsakoff, Parkinson’s disease dementia, Lewy Body dementia and Alzheimer’s disease.

‘We will continue to harness this expertise and innovation to support pioneering projects to find better treatments

Health and Social Care Secretary, Sajid Javid

The government have already given £7 million to support clinical trails and research into MND. The additional funding will see a new NIHR Research Unit set up, to coordinate research applications and encourage further innovative studies.

Health and Social Care Secretary, Sajid Javid, said: ‘Neurodegenerative conditions like MND can have a devastating impact on people’s lives and I’m committed to ensuring the government does everything we can to fight these diseases and support those affected.

‘We’ve already invested millions in understanding and treating MND and our new funding commitment will back more research into this and other neurodegenerative diseases.

‘The UK is a global leader in medical research. Our world-class research sector was central to the discovery of lifesaving treatments for COVID-19 like dexamethasone and Tocilizumab, as well as the development of the vaccine programme which has saved hundreds of thousands of lives.

‘We will continue to harness this expertise and innovation to support pioneering projects to find better treatments for those living with motor neurone disease, like the excellent work underway at NIHR Sheffield Biomedical Research Centre where scientists are trialling new drugs to treat the condition.’

Business Secretary Kwasi Kwarteng said, ‘the UK is home to some of the most transformative and innovative medical research in the world, and the availability of this research funding, alongside the work of our strong life science and pharmaceuticals sector, will make the most of that research to help those living with motor neurone disease.

‘It is vital that we increase our understanding of this condition in pursuit of new treatments and better care, and I am pleased to see UK institutions at the forefront of that work.’

As well as the funding, a new motor neurone disease partnership will be formed to bring together expertise and resources across the research community to speed up the delivery of new treatments. The collaboration, backed by £4 million, is co-funded by the National Institute for Health Research, UK Research and Innovation, Life Arc, MND Association and My Name’5 Doddie Foundation.

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all